Bank of America enters the next three years with solid earnings capacity and a stronger share price, supported by steady revenue and fee initiatives. On a trailing basis, revenue stands at $98.46B and net income at $26.59B, with profit margin of 28.51% and return on equity of 9.46%. Shares recently traded near the 52‑week high, with the last weekly close at $50.58 versus a 52‑week range of $33.07–$50.96 and a 52‑week change of 31.31%. The bank’s dividend policy remains measured, with a forward yield of 2.21% and a 30.50% payout ratio. Near term, performance hinges on the interest‑rate path, credit trends, and operating discipline after a volatile spring. Longer term, BAC’s scale in digital banking and wealth management—plus new partnerships—positions it to grow fee income while maintaining prudent capital returns.

Johnson & Johnson (JNJ) enters September 2025 with resilient fundamentals and a steadier share price. The healthcare giant reports $90.63B in trailing 12‑month revenue, a 25.0% profit margin, and $30.25B in EBITDA, supported by $23.03B in operating cash flow and $11.08B in levered free cash flow. The stock has rebounded toward its 52‑week high of $181.16, closing recently around $178, while maintaining a low 0.39 beta and a forward dividend yield near 2.91% with a 53.75% payout ratio. Balance‑sheet capacity remains ample with $18.88B in cash against $50.76B in debt and a current ratio of 1.01. Headlines center on a $2B U.S. manufacturing investment, tariff‑policy uncertainty, and mixed analyst sentiment, including a $200 target from Citi and a scenario for $250 outlined by Forbes. This note outlines a three‑year outlook through September 2028.

Procter & Gamble enters late 2025 with resilient fundamentals and a stock that has lagged the broader market. The consumer‑staples giant generated $84.28B in trailing 12‑month revenue and $15.68B in net income, supported by a 25.15% operating margin and 18.95% profit margin. Cash generation remains strong, with $17.82B in operating cash flow and $11.38B in levered free cash flow, helping fund a forward annual dividend of $4.23 (2.69% yield; payout ratio 62.62%). Shares recently closed at $158.63, down 9.29% over 52 weeks versus the S&P 500’s 16.73% gain, while the stock’s 0.36 beta underscores its defensive profile. With quarterly revenue growth at 1.70% and quarterly earnings growth at 15.20% year over year, the three‑year outlook hinges on sustaining margin discipline, product innovation, and execution amid changing consumer demand.

Exxon Mobil enters September 2025 with shares near $112.14 and a defensive profile underpinned by integrated operations, steady cash generation, and a commitment to dividends. Trailing 12-month revenue is $329.82 billion with a 9.40% profit margin and 11.73% operating margin, though quarterly revenue and earnings declined year over year (−12.30% and −23.40%, respectively). Operating cash flow of $54.3 billion and levered free cash flow of $20.75 billion support a forward dividend yield of 3.52% with a 55.68% payout ratio. The stock trades close to its 50- and 200-day moving averages (110.42 and 109.67) and carries a 0.55 beta. Recent coverage cites a $125.00 consensus price target, implying potential upside versus the latest close. Against this mixed backdrop, our three-year outlook weighs cash flow durability, capital returns, and macro sensitivity to chart plausible paths for the shares.